📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway (2015)

First Author: Curry E

Attributed to: Confidence in Concept 2012 - Imperial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1538-8514.pi3k14-a47

Publication URI: http://dx.doi.org/10.1158/1538-8514.pi3k14-a47

Type: Journal Article/Review

Parent Publication: Molecular Cancer Therapeutics

Issue: 7_Supplement